T, G., BL, M., KM, M., L, B., M, F., KM, P., . . . AJ, P. (2026). Therapeutic outcomes of patients with acute erythroid leukemia treated with hypomethylating agents. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 32(5), 894. https://doi.org/10.1177/10781552251323578
Chicago Style (17th ed.) CitationT, Gabbard, Marini BL, Mirza KM, Benitez L, Fraga M, Pettit KM, Bixby DL, Burke PW, and Perissinotti AJ. "Therapeutic Outcomes of Patients with Acute Erythroid Leukemia Treated with Hypomethylating Agents." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 32, no. 5 (2026): 894. https://doi.org/10.1177/10781552251323578.
MLA (9th ed.) CitationT, Gabbard, et al. "Therapeutic Outcomes of Patients with Acute Erythroid Leukemia Treated with Hypomethylating Agents." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, vol. 32, no. 5, 2026, p. 894, https://doi.org/10.1177/10781552251323578.